MOXYROOT-CV 625
Amoxycillin and Potassium Clavulanate Tablets
Marketed By: Medroots Biopharma Pvt. Ltd.
A Trusted PCD Pharma Company
MOXYROOT-CV 625 is a combination antibiotic formulation containing Amoxycillin and Potassium Clavulanate, widely prescribed for the treatment of various bacterial infections. The combination helps enhance antibacterial effectiveness against a broad range of bacteria.
Composition
Each film-coated tablet contains:
Amoxycillin Trihydrate IP equivalent to Amoxycillin – 500 mg
Potassium Clavulanate Diluted IP equivalent to Clavulanic Acid – 125 mg
Indications
MOXYROOT-CV 625 is commonly prescribed for the treatment of bacterial infections such as:
Respiratory tract infections
Ear, nose, and throat infections
Urinary tract infections
Skin and soft tissue infections
Dental infections
Lower respiratory tract infections
Benefits
Broad-spectrum antibacterial action
Helps fight resistant bacterial strains
Effective combination therapy for multiple infections
Trusted formulation for quality healthcare support
Dosage
Use strictly as directed by a registered medical practitioner.
Complete the full prescribed course for best results.
Precautions
To be used only under medical supervision
Inform your doctor about any allergy to penicillin or antibiotics
Use with caution in patients with liver or kidney disorders
Do not self-medicate or discontinue without medical advice
Storage Instructions
Store in a cool and dry place
Protect from moisture and direct sunlight
Keep out of reach of children
Why Choose MOXYROOT-CV 625?
Quality-assured pharmaceutical formulation
Manufactured and marketed with high standards
Reliable product from Medroots Biopharma Pvt. Ltd.
Suitable for pharma franchise and PCD business opportunities
